Chapter/Section Purchase

1 Study Coverage
1.1 Hyperimmune Serum Product Introduction
1.2 Market by Type
1.2.1 Global Hyperimmune Serum Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Rho(D) Immunoglobulins
1.2.6 Other
1.3 Market by Application
1.3.1 Global Hyperimmune Serum Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Hyperimmune Serum Sales Estimates and Forecasts 2017-2028
2.2 Global Hyperimmune Serum Revenue Estimates and Forecasts 2017-2028
2.3 Global Hyperimmune Serum Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Hyperimmune Serum Sales by Region
2.4.1 Global Hyperimmune Serum Sales by Region (2017-2022)
2.4.2 Global Sales Hyperimmune Serum by Region (2023-2028)
2.5 Global Hyperimmune Serum Revenue by Region
2.5.1 Global Hyperimmune Serum Revenue by Region (2017-2022)
2.5.2 Global Hyperimmune Serum Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Hyperimmune Serum Sales by Manufacturers
3.1.1 Global Top Hyperimmune Serum Manufacturers by Sales (2017-2022)
3.1.2 Global Hyperimmune Serum Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hyperimmune Serum in 2021
3.2 Global Hyperimmune Serum Revenue by Manufacturers
3.2.1 Global Hyperimmune Serum Revenue by Manufacturers (2017-2022)
3.2.2 Global Hyperimmune Serum Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Hyperimmune Serum Revenue in 2021
3.3 Global Hyperimmune Serum Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Hyperimmune Serum Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Hyperimmune Serum Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hyperimmune Serum Sales by Type
4.1.1 Global Hyperimmune Serum Historical Sales by Type (2017-2022)
4.1.2 Global Hyperimmune Serum Forecasted Sales by Type (2023-2028)
4.1.3 Global Hyperimmune Serum Sales Market Share by Type (2017-2028)
4.2 Global Hyperimmune Serum Revenue by Type
4.2.1 Global Hyperimmune Serum Historical Revenue by Type (2017-2022)
4.2.2 Global Hyperimmune Serum Forecasted Revenue by Type (2023-2028)
4.2.3 Global Hyperimmune Serum Revenue Market Share by Type (2017-2028)
4.3 Global Hyperimmune Serum Price by Type
4.3.1 Global Hyperimmune Serum Price by Type (2017-2022)
4.3.2 Global Hyperimmune Serum Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Hyperimmune Serum Sales by Application
5.1.1 Global Hyperimmune Serum Historical Sales by Application (2017-2022)
5.1.2 Global Hyperimmune Serum Forecasted Sales by Application (2023-2028)
5.1.3 Global Hyperimmune Serum Sales Market Share by Application (2017-2028)
5.2 Global Hyperimmune Serum Revenue by Application
5.2.1 Global Hyperimmune Serum Historical Revenue by Application (2017-2022)
5.2.2 Global Hyperimmune Serum Forecasted Revenue by Application (2023-2028)
5.2.3 Global Hyperimmune Serum Revenue Market Share by Application (2017-2028)
5.3 Global Hyperimmune Serum Price by Application
5.3.1 Global Hyperimmune Serum Price by Application (2017-2022)
5.3.2 Global Hyperimmune Serum Price Forecast by Application (2023-2028)
6 North America
6.1 North America Hyperimmune Serum Market Size by Type
6.1.1 North America Hyperimmune Serum Sales by Type (2017-2028)
6.1.2 North America Hyperimmune Serum Revenue by Type (2017-2028)
6.2 North America Hyperimmune Serum Market Size by Application
6.2.1 North America Hyperimmune Serum Sales by Application (2017-2028)
6.2.2 North America Hyperimmune Serum Revenue by Application (2017-2028)
6.3 North America Hyperimmune Serum Market Size by Country
6.3.1 North America Hyperimmune Serum Sales by Country (2017-2028)
6.3.2 North America Hyperimmune Serum Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Hyperimmune Serum Market Size by Type
7.1.1 Europe Hyperimmune Serum Sales by Type (2017-2028)
7.1.2 Europe Hyperimmune Serum Revenue by Type (2017-2028)
7.2 Europe Hyperimmune Serum Market Size by Application
7.2.1 Europe Hyperimmune Serum Sales by Application (2017-2028)
7.2.2 Europe Hyperimmune Serum Revenue by Application (2017-2028)
7.3 Europe Hyperimmune Serum Market Size by Country
7.3.1 Europe Hyperimmune Serum Sales by Country (2017-2028)
7.3.2 Europe Hyperimmune Serum Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Hyperimmune Serum Market Size by Type
8.1.1 Asia Pacific Hyperimmune Serum Sales by Type (2017-2028)
8.1.2 Asia Pacific Hyperimmune Serum Revenue by Type (2017-2028)
8.2 Asia Pacific Hyperimmune Serum Market Size by Application
8.2.1 Asia Pacific Hyperimmune Serum Sales by Application (2017-2028)
8.2.2 Asia Pacific Hyperimmune Serum Revenue by Application (2017-2028)
8.3 Asia Pacific Hyperimmune Serum Market Size by Region
8.3.1 Asia Pacific Hyperimmune Serum Sales by Region (2017-2028)
8.3.2 Asia Pacific Hyperimmune Serum Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Hyperimmune Serum Market Size by Type
9.1.1 Latin America Hyperimmune Serum Sales by Type (2017-2028)
9.1.2 Latin America Hyperimmune Serum Revenue by Type (2017-2028)
9.2 Latin America Hyperimmune Serum Market Size by Application
9.2.1 Latin America Hyperimmune Serum Sales by Application (2017-2028)
9.2.2 Latin America Hyperimmune Serum Revenue by Application (2017-2028)
9.3 Latin America Hyperimmune Serum Market Size by Country
9.3.1 Latin America Hyperimmune Serum Sales by Country (2017-2028)
9.3.2 Latin America Hyperimmune Serum Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Hyperimmune Serum Market Size by Type
10.1.1 Middle East and Africa Hyperimmune Serum Sales by Type (2017-2028)
10.1.2 Middle East and Africa Hyperimmune Serum Revenue by Type (2017-2028)
10.2 Middle East and Africa Hyperimmune Serum Market Size by Application
10.2.1 Middle East and Africa Hyperimmune Serum Sales by Application (2017-2028)
10.2.2 Middle East and Africa Hyperimmune Serum Revenue by Application (2017-2028)
10.3 Middle East and Africa Hyperimmune Serum Market Size by Country
10.3.1 Middle East and Africa Hyperimmune Serum Sales by Country (2017-2028)
10.3.2 Middle East and Africa Hyperimmune Serum Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Corporation Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSL Behring Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Corporation Information
11.2.2 Grifols Overview
11.2.3 Grifols Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Grifols Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Biotest
11.3.1 Biotest Corporation Information
11.3.2 Biotest Overview
11.3.3 Biotest Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Biotest Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest Recent Developments
11.4 Kedrion
11.4.1 Kedrion Corporation Information
11.4.2 Kedrion Overview
11.4.3 Kedrion Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kedrion Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion Recent Developments
11.5 CBPO
11.5.1 CBPO Corporation Information
11.5.2 CBPO Overview
11.5.3 CBPO Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CBPO Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CBPO Recent Developments
11.6 Emergent (Cangene)
11.6.1 Emergent (Cangene) Corporation Information
11.6.2 Emergent (Cangene) Overview
11.6.3 Emergent (Cangene) Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Emergent (Cangene) Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent (Cangene) Recent Developments
11.7 Kamada
11.7.1 Kamada Corporation Information
11.7.2 Kamada Overview
11.7.3 Kamada Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Kamada Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kamada Recent Developments
11.8 CNBG
11.8.1 CNBG Corporation Information
11.8.2 CNBG Overview
11.8.3 CNBG Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 CNBG Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Corporation Information
11.9.2 Hualan Bio Overview
11.9.3 Hualan Bio Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Bio Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Bio Recent Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Corporation Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Shanghai RAAS Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai RAAS Recent Developments
11.11 Sichuan Yuanda Shuyang
11.11.1 Sichuan Yuanda Shuyang Corporation Information
11.11.2 Sichuan Yuanda Shuyang Overview
11.11.3 Sichuan Yuanda Shuyang Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sichuan Yuanda Shuyang Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sichuan Yuanda Shuyang Recent Developments
11.12 ADMA Biologics
11.12.1 ADMA Biologics Corporation Information
11.12.2 ADMA Biologics Overview
11.12.3 ADMA Biologics Hyperimmune Serum Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 ADMA Biologics Hyperimmune Serum Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ADMA Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hyperimmune Serum Industry Chain Analysis
12.2 Hyperimmune Serum Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hyperimmune Serum Production Mode & Process
12.4 Hyperimmune Serum Sales and Marketing
12.4.1 Hyperimmune Serum Sales Channels
12.4.2 Hyperimmune Serum Distributors
12.5 Hyperimmune Serum Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Hyperimmune Serum Industry Trends
13.2 Hyperimmune Serum Market Drivers
13.3 Hyperimmune Serum Market Challenges
13.4 Hyperimmune Serum Market Restraints
14 Key Findings in The Global Hyperimmune Serum Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer